5MRA
human SCBD (sorcin calcium binding domain) in complex with doxorubicin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE MASSIF-3 |
Synchrotron site | ESRF |
Beamline | MASSIF-3 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2016-03-05 |
Detector | DECTRIS EIGER R 4M |
Wavelength(s) | 0.9677 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 92.229, 104.831, 113.273 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 76.940 - 3.740 |
R-factor | 0.19623 |
Rwork | 0.192 |
R-free | 0.28501 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4upg |
RMSD bond length | 0.010 |
RMSD bond angle | 1.324 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0155) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 76.940 | 3.960 |
High resolution limit [Å] | 3.740 | 3.740 |
Rmerge | 0.102 | |
Number of reflections | 11800 | |
<I/σ(I)> | 11.81 | 1.45 |
Completeness [%] | 99.0 | 97.2 |
Redundancy | 6.53 | 6.47 |
CC(1/2) | 0.998 | 0.561 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7 | 298 | 0.2 M MgCl2, 0.1 M Tris pH=7, NaCl 2.5 M |